[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"CardioFocus\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":67},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,45],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":29,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100579795","pulmonary-vein-isolation-with-the-single-shot-endoscopic-ultra-compliant-pfa-balloon-for-the-treatment-of-af-100579795",false,"NCT06828939","Pulmonary Vein Isolation With the Single Shot Endoscopic Ultra-Compliant PFA Balloon for the Treatment of AF","Pulmonary Vein Isolation With the Single Shot Endoscopic Ultra-Compliant Pulsed Field Ablation Balloon for the Treatment of Atrial Fibrillation","VISION AF","Inclusion Criteria:\n\n* Recurrent symptomatic PAF with at least one documented episode\n* Failure or intolerance of at least one AAD\n* Age 18-75 years\n* Patient is indicated for an ablation procedure according to society guidelines or study site practice\n* Patient is willing and able to give informed consent\u002Fparticipate in baseline and follow-up assessments for the duration of the study\n\nExclusion Criteria:\n\n* overall good health as established by multiple criteria","ALL","18 Years","75 Years",{"count":21,"type":22},100,"ESTIMATED","INTERVENTIONAL",[25],"NA","This is a prospective, single-arm First-in-Human study to demonstrate the safety and effectiveness of the CardioFocus OptiShot Pulsed Field Ablation System for catheter ablation of atrial fibrillation (AF). Patients with symptomatic paroxysmal (short-duration) AF who have not had a previous catheter ablation for AF will be considered for the study. Patients will be followed for one year after the initial ablation procedure.",[28],"Atrial Fibrillation (Paroxysmal)",[30,31],"ablation","pulsed field ablation","RECRUITING","2026-07-31",{"date":35,"type":36},"2026-08-03","ACTUAL",{"date":38,"type":36},"2024-12-12",{"date":40,"type":22},"2027-12-31",{"name":42,"class":43},"CardioFocus","INDUSTRY",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":52,"targetDuration":4,"studyType":23,"phases":54,"briefSummary":55,"conditions":56,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":66},"100298716","cardiofocus-heartlight-post-approval-study-100298716","NCT03168659","CardioFocus HeartLight Post-Approval Study","Post-Approval Study of the HeartLight Endoscopic Ablation System for the Treatment of Atrial Fibrillation","Inclusion Criteria:\n\n* 18 years or older\n* planned for catheter ablation due to symptomatic paroxysmal atrial fibrillation\n* failure of at least one anti-arrhythmic drug\n* others\n\nExclusion Criteria:\n\n* overall good health as established by multiple criteria",{"count":53,"type":22},250,[25],"This is a post-approval study to evaluate the clinical outcomes in a cohort of participants treated during commercial use of the HeartLight System to confirm results of the previously conducted pivotal clinical study.",[57],"Atrial Fibrillation","2024-08-19",{"date":60,"type":36},"2024-08-20",{"date":62,"type":36},"2017-06-16",{"date":64,"type":22},"2028-10",{"name":42,"class":43},4,""]